Package:
VIAL (powder)1 + 1 syringe of diluent (0.5 ml). Dosage:
I.M. or S.C. route. See prescribing information for full details. Prescribing Restrictions: None
Indications:
Prevention in infants of invasive disease caused by Hemophilus influenza type B (meningitis, septicemia, cellulitis, arthritis, epiglotitis. Contra-Indications:
Hypersensitivity to components, especially to the tetanus protein. Special Precautions:
Persons deficient in producing antibody, whether due to genetic defect or to immunosuppressive therapy, the expected immune response may not be obtained. Not recommended during pregnancy. See prescribing information for full details. Side Effects:
Pain, erythema, induration of the injection site. See prescribing information for full details. Drug Interactions:
See prescribing information for full details.